PharmaCyte Biotech, Inc.
PMCB
$1.04
$0.032.97%
NASDAQ
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -58.82% | -69.03% | -72.63% | -71.62% | -56.29% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -0.83% | -13.86% | -30.36% | 52.60% | 170.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -41.88% | -55.64% | -72.42% | -71.07% | -56.02% |
|
|
|||||
| Total Current Assets | -41.88% | -55.64% | -72.42% | -71.07% | -56.02% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | -56.35% | -56.35% | -56.35% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -27.52% | 10.80% | 41.36% | 95,493.51% | 86,259.74% |
| Total Assets | -35.73% | -7.91% | -38.58% | -30.15% | -12.13% |
|
|
|||||
| Total Accounts Payable | -16.03% | 2.52% | 0.14% | 176.23% | -22.85% |
| Total Accrued Expenses | -49.47% | -29.12% | -8.39% | -30.54% | 42.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -95.99% | -68.33% | -- | 547.72% | 1,849.62% |
| Total Other Current Liabilities | -95.99% | -68.33% | -- | 547.72% | 1,849.62% |
| Total Current Liabilities | -85.80% | -60.73% | -46.91% | 177.88% | 392.29% |
|
|
|||||
| Total Current Liabilities | -85.80% | -60.73% | -46.91% | 177.88% | 392.29% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -95.27% | -97.20% | -84.03% | -55.88% | -48.73% |
| Total Liabilities | -91.14% | -83.93% | -79.17% | -32.64% | -15.90% |
|
|
|||||
| Common Stock & APIC | -0.64% | -2.07% | -4.12% | -6.32% | -9.65% |
| Retained Earnings | -1.22% | 26.51% | 17.31% | 19.49% | 22.82% |
| Treasury Stock & Other | -4.25% | -6.11% | -8.76% | -9.28% | -6.92% |
| Total Common Equity | -8.63% | 87.69% | 28.29% | 18.18% | 11.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -68.17% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -68.17% |
|
|
|||||
| Total Common Equity | -8.63% | 87.69% | 28.29% | 18.18% | 11.65% |
| Total Preferred Equity | -- | -- | -- | -- | -68.17% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -17.82% | 31.32% | -25.71% | -29.45% | -10.83% |
|
|
|||||